<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Diagn Pathol</journal-id>
      <journal-id journal-id-type="iso-abbrev">Diagn Pathol</journal-id>
      <journal-title-group>
        <journal-title>Diagnostic Pathology</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1746-1596</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">27506465</article-id>
      <article-id pub-id-type="pmc">4979129</article-id>
      <article-id pub-id-type="publisher-id">516</article-id>
      <article-id pub-id-type="doi">10.1186/s13000-016-0516-0</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Maturation toward neuronal tissue in a Ewing sarcoma of bone after chemotherapy</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Salet</surname>
            <given-names>Maria Carolina Wilhelmina</given-names>
          </name>
          <address>
            <email>Myrthe.Salet@radboudumc.nl</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Vogels</surname>
            <given-names>Rob</given-names>
          </name>
          <address>
            <email>Rob.Vogels@radboudumc.nl</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Brons</surname>
            <given-names>Paul</given-names>
          </name>
          <address>
            <email>Paul.Brons@radboudumc.nl</email>
          </address>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Schreuder</surname>
            <given-names>Bart</given-names>
          </name>
          <address>
            <email>Bart.Schreuder@radboudumc.nl</email>
          </address>
          <xref ref-type="aff" rid="Aff3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Flucke</surname>
            <given-names>Uta</given-names>
          </name>
          <address>
            <email>Uta.Flucke@radboudumc.nl</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <aff id="Aff1"><label>1</label>Department of Pathology, Radboud University Medical Center, P.O. Box 9101, Nijmegen, 6500 HB The Netherlands </aff>
        <aff id="Aff2"><label>2</label>Department of Pediatric Oncology, Radboud University center, P.O. Box 9101, Nijmegen, 6500 HB The Netherlands </aff>
        <aff id="Aff3"><label>3</label>Department of Orthopedics, Radboud University Center, P.O. Box 9101, Nijmegen, 6500 HB The Netherlands </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>9</day>
        <month>8</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>9</day>
        <month>8</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2016</year>
      </pub-date>
      <volume>11</volume>
      <elocation-id>74</elocation-id>
      <history>
        <date date-type="received">
          <day>23</day>
          <month>1</month>
          <year>2016</year>
        </date>
        <date date-type="accepted">
          <day>19</day>
          <month>7</month>
          <year>2016</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; The Author(s). 2016</copyright-statement>
        <license license-type="OpenAccess">
          <license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <sec>
          <title>Background</title>
          <p>Ewing sarcoma is the second most common bone tumor, occurring mainly in children and young adults. It shows a typical primitive, small round cell morphology and a characteristic fusion oncogene involving <italic>EWSR1</italic> and members of the ETS family in most of the cases. Neuronal maturation after chemotherapy is a rare phenomenon and we herein describe such an exceptional case.</p>
        </sec>
        <sec>
          <title>Case presentation</title>
          <p>An 8-year old boy was diagnosed with a Ewing sarcoma in the left femur. On biopsy the morphology was typical and there was an <italic>EWSR1-FLI1</italic> gene fusion. He underwent neo-adjuvant chemotherapy and resection of the tumor. On microscopic evaluation, part of the tumor showed ganglioneuroblastoma-like differentiation with expression of neuronal markers. The continued presence of <italic>EWSR1</italic> rearrangement in both the blue round cell component and the ganglioneuroblastoma-like component was shown by FISH analysis.</p>
        </sec>
        <sec>
          <title>Conclusions</title>
          <p>In conclusion, this case describes the possibility of a Ewing sarcoma to differentiate into a ganglioneuroblastoma-like lesion after neo-adjuvant chemotherapy treatment; the prognostic value of this phenomenon remains questionable.</p>
        </sec>
        <sec>
          <title>Electronic supplementary material</title>
          <p>The online version of this article (doi:10.1186/s13000-016-0516-0) contains supplementary material, which is available to authorized users.</p>
        </sec>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd>Ewing sarcoma</kwd>
        <kwd>Pathology</kwd>
        <kwd>Maturation</kwd>
        <kwd>Differentiation</kwd>
        <kwd>Neural</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; The Author(s) 2016</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1">
      <title>Background</title>
      <p>Ewing sarcoma, first described by James Ewing in 1921, is the second most common malignant bone tumor after osteosarcoma. Occurring mainly in children and young adults; it accounts for 3&#xA0;% of childhood malignancies. During the last decades, the 5&#xA0;year overall survival has improved up to 85&#xA0;% for patients with localized disease but is still only 30&#xA0;% for patients with metastatic disease [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. Ewing sarcomas are primitive small blue round cell tumors of bone and soft tissue, characterized by the expression of <italic>EWS-ETS</italic> fusion genes as a driver mutation [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR4">4</xref>].</p>
      <p>Neural differentiation in Ewing sarcoma is a rare phenomenon and has been described before in a few cases [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR5">5</xref>]. Here we present a case in which an Ewing sarcoma shows ganglioneuroblastoma-like differentiation after chemotherapeutic treatment.</p>
    </sec>
    <sec id="Sec2">
      <title>Case presentation</title>
      <p>An 8-year old boy with no previous relevant medical history, presented with pain and a palpable mass in the left upper thigh. MRI showed a ca. 10&#xA0;cm large lesion in the femur with soft tissue extension. There were no signs of metastasis elsewhere. The patient received neo-adjuvant chemotherapy by the Ewing 2008 protocol. After 4&#xA0;cycles of VIDE (vincristine, ifosfamide, doxorubicin and etoposide) chemotherapy, a staging FDG-PET/CT-scan was performed, showing tumor regression, however no normalization of metabolic activity at the primary tumor site. After 6&#xA0;cycles of VIDE, resection of the femur diaphysis was performed with reconstruction with a vascularised fibula transplant. An optimal recovery has been seen so far, with no sign of recurrence or metastatic disease at 21&#xA0;months after surgery.</p>
      <sec id="Sec3">
        <title>Histology</title>
        <sec id="Sec4">
          <title>Biopsy</title>
          <p>The pretreatment biopsy (routinely formalin-fixed, paraffin-embedded, decalcified and hematoxylin-eosin-stained) revealed microscopically a small blue round cell tumor with necrosis. A panel of antibodies was applied according to standard protocol (antibodies used can be seen in Additional file <xref rid="MOESM1" ref-type="media">1</xref>). There was positive membranous staining for CD99 and CD56, consistent with the diagnosis of Ewing sarcoma. By RT-PCR, the presence of the <italic>EWSR1-FLI1</italic> fusion gene confirmed this diagnosis.</p>
        </sec>
        <sec id="Sec5">
          <title>Resection specimen</title>
          <p>Macroscopically, a 15&#xA0;cm measuring femur bone and surrounding soft tissue specimen, showed on the cut surface a 10.5&#xA0;cm large tumor with soft tissue extension. Necrosis, cystic and myxoid changes as well as areas of hemorrhage were present. Microscopy of the tumor showed, beside the usual small blue round cell population, maturated neuroblastoma-like cells and ganglion-like cells against a fibrillary (neuropil-like) background (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>). It was estimated that of the surviving tumor load about 70&#xA0;% showed neural differentiation. Again, there was a membrane reactivity for CD99 in the primitive population, whereas the ganglioneuroblastoma-like component showed expression of neural markers, including NF, Neu-N and GFAP. There was no S100 expression (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2</xref>). To confirm the continued presence of the fusion gene FISH analysis was performed showing rearrangement of <italic>EWSR1</italic> in both the small blue round cell component and the ganglioneuroblastoma-like component.<fig id="Fig1"><label>Fig. 1</label><caption><p>Resection specimen showing ganglioneuroblastoma-like differentiation. <bold>a</bold>: Overview (2.5x) (<bold>b</bold>): 10x (<bold>c</bold>): 20x (<bold>d</bold>): 40x</p></caption><graphic xlink:href="13000_2016_516_Fig1_HTML" id="MO1"/></fig><fig id="Fig2"><label>Fig. 2</label><caption><p>Immunohistochemistry on resection specimen (40x) (<bold>a</bold>) HE showing a part of the tumor with both differentiated (neuronal and ganglion-like cell) and small groups of primitive (typical Ewing) tumor cells (<bold>b</bold>) NF Highlights part of the differentiated tumor cells and the neuropil. The primitive tumor cells are mainly negative (<bold>c</bold>) CD99 labels the primitive tumor cells, whereas the differentiated component is negative. <bold>d</bold> Neu-N shows strong reactivity of the differentiated tumor cells and is negative in the primitive tumor cells</p></caption><graphic xlink:href="13000_2016_516_Fig2_HTML" id="MO2"/></fig></p>
        </sec>
      </sec>
    </sec>
    <sec id="Sec6">
      <title>Discussion</title>
      <p>The cellular origin of Ewing sarcomas remains both elusive and controversial. However, the immature neural phenotype of many tumors, formerly known as PNET [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR6">6</xref>], along with their gene expression signatures and their disposition to neural differentiation in experimental models implicate a neural crest stem cell genetic program as integral feature of pathogenesis of Ewing sarcoma [<xref ref-type="bibr" rid="CR7">7</xref>]. Therefore, it is not surprising that patient material, at least in some cases, show (ganglio) neuroblastoma-like morphology.</p>
      <p>Delattre et al. and Burchill et al. described neuroblastoma-like features in a few untreated Ewing sarcoma cases with genetic confirmation [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR9">9</xref>], which could be a diagnostic pitfall.</p>
      <p>On the other hand, our case and the reported cases by Maeda et al. and Collini et al. show ganglioneuroblastoma-like maturation after chemotherapy probably as treatment effect (3,5).</p>
      <p>Whereas Maeda et al. confirmed their diagnosis molecularly only on biopsy material (5), Collini et al. demonstrated the presence of the <italic>EWSR1-FLI1</italic> fusion gene in both pre- and post-treatment specimens, as we did in our case [<xref ref-type="bibr" rid="CR3">3</xref>].</p>
      <p>However, such cases are very rare, we didn&#x2019;t find another one when reviewing 26 cases from our archives. This is in line with the results of Delattre et al. investigating a series of more than 90 cases with two neuroblastoma-like instances [<xref ref-type="bibr" rid="CR8">8</xref>].</p>
      <p>Maturation during chemotherapeutic treatment is a more common finding in other primitive pediatric tumors such as rhabdomyosarcoma and neuroblastoma [<xref ref-type="bibr" rid="CR10">10</xref>&#x2013;<xref ref-type="bibr" rid="CR13">13</xref>]. Since neural maturation is very rare in Ewing sarcoma, the prognostic value remains unclear in comparison to e.g., embryonal rhabdomyosarcoma where it is associated with favorable outcome [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR14">14</xref>]. At least the case by Maeda et al. had a unfavorable outcome with metastatic disease showing typical small blue round cell morphology of Ewing sarcoma in contrast to our case with no signs of recurrence or metastases at 21&#xA0;month after surgery [<xref ref-type="bibr" rid="CR5">5</xref>].</p>
    </sec>
    <sec id="Sec7">
      <title>Conclusions</title>
      <p>In conclusion, this case describes the possibility of a Ewing sarcoma to differentiate into neural tissue after neo-adjuvant chemotherapy treatment, the prognostic value of this phenomenon remains questionable.</p>
    </sec>
    <sec id="Sec8">
      <title>Abbreviations</title>
      <p>CT, computed tomography; FDG, fluordeoxyglucose; GFAP, glial fibrillary acidic protein; HE, hematoxylin-eosin; MRI, magnetic resonance imaging; Neu-N, neuronal nuclei; NF, neurofilament; PET/CT, positron emission tomography&#x2013;computed tomography; PNET, primitive neuroectodermal tumor</p>
    </sec>
  </body>
  <back>
    <app-group>
      <app id="App1">
        <sec id="Sec22">
          <title>Additional file</title>
          <p>
            <media position="anchor" xlink:href="13000_2016_516_MOESM1_ESM.xlsx" id="MOESM1">
              <label>Additional file 1:</label>
              <caption>
                <p>The used antibodies. (XLSX 10kb)</p>
              </caption>
            </media>
          </p>
        </sec>
      </app>
    </app-group>
    <ack>
      <title>Acknowledgements</title>
      <p>Not applicable.</p>
      <sec id="FPar1">
        <title>Funding</title>
        <p>No funding was received.</p>
      </sec>
      <sec id="FPar2">
        <title>Availability of data and materials</title>
        <p>The dataset supporting the conclusions of this article is included within the article.</p>
      </sec>
      <sec id="FPar3">
        <title>Authors&#x2019; contributions</title>
        <p>MS wrote the manuscript. PB and BS were involved in the treatment of the patient. UF and RV revised the manuscript. All authors read and approved the final manuscript.</p>
      </sec>
      <sec id="FPar4">
        <title>Competing interests</title>
        <p>The authors declare that they have no competing interests.</p>
      </sec>
      <sec id="FPar5">
        <title>Consent for publication</title>
        <p>Written informed consent was obtained from the guardian of the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.</p>
      </sec>
      <sec id="FPar6">
        <title>Ethics approval and consent to participate</title>
        <p>Not applicable.</p>
      </sec>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <mixed-citation publication-type="other">Hamilton SN et al. Long-term Outcomes and Complications in Pediatric Ewing Sarcoma. Am J Clin Oncol. 2015.</mixed-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rodriguez-Galindo</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Analysis of prognostic factors in ewing sarcoma family of tumors: review of St. Jude Children&#x2019;s Research Hospital studies</article-title>
          <source>Cancer</source>
          <year>2007</year>
          <volume>110</volume>
          <issue>2</issue>
          <fpage>375</fpage>
          <lpage>84</lpage>
          <pub-id pub-id-type="doi">10.1002/cncr.22821</pub-id>
          <pub-id pub-id-type="pmid">17569105</pub-id>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Collini</surname>
              <given-names>P</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Evidence of neural differentiation in a case of post-therapy primitive neuroectodermal tumor/Ewing sarcoma of bone</article-title>
          <source>Am J Surg Pathol</source>
          <year>2003</year>
          <volume>27</volume>
          <issue>8</issue>
          <fpage>1161</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="doi">10.1097/00000478-200308000-00016</pub-id>
          <pub-id pub-id-type="pmid">12883251</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Arvand</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Denny</surname>
              <given-names>CT</given-names>
            </name>
          </person-group>
          <article-title>Biology of EWS/ETS fusions in Ewing&#x2019;s family tumors</article-title>
          <source>Oncogene</source>
          <year>2001</year>
          <volume>20</volume>
          <issue>40</issue>
          <fpage>5747</fpage>
          <lpage>54</lpage>
          <pub-id pub-id-type="doi">10.1038/sj.onc.1204598</pub-id>
          <pub-id pub-id-type="pmid">11607824</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Maeda</surname>
              <given-names>G</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Ganglion cells in Ewing&#x2019;s sarcoma following chemotherapy: a case report</article-title>
          <source>Pathol Int</source>
          <year>1998</year>
          <volume>48</volume>
          <issue>6</issue>
          <fpage>475</fpage>
          <lpage>80</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1440-1827.1998.tb03936.x</pub-id>
          <pub-id pub-id-type="pmid">9702862</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jaffe</surname>
              <given-names>R</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The neuroectodermal tumor of bone</article-title>
          <source>Am J Surg Pathol</source>
          <year>1984</year>
          <volume>8</volume>
          <issue>12</issue>
          <fpage>885</fpage>
          <lpage>98</lpage>
          <pub-id pub-id-type="doi">10.1097/00000478-198412000-00001</pub-id>
          <pub-id pub-id-type="pmid">6083729</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>von Levetzow</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Modeling initiation of Ewing sarcoma in human neural crest cells</article-title>
          <source>PLoS One</source>
          <year>2011</year>
          <volume>6</volume>
          <issue>4</issue>
          <fpage>e19305</fpage>
          <pub-id pub-id-type="doi">10.1371/journal.pone.0019305</pub-id>
          <pub-id pub-id-type="pmid">21559395</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Delattre</surname>
              <given-names>O</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The Ewing Family of Tumors - a Subgroup of Small-Round-Cell Tumors Defined by Specific Chimeric Transcripts</article-title>
          <source>N Engl J Med</source>
          <year>1994</year>
          <volume>331</volume>
          <issue>5</issue>
          <fpage>294</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="doi">10.1056/NEJM199408043310503</pub-id>
          <pub-id pub-id-type="pmid">8022439</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Burchill</surname>
              <given-names>SA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>EWS-FLI1 fusion transcripts identified in patients with typical neuroblastoma</article-title>
          <source>Eur J Cancer</source>
          <year>1997</year>
          <volume>33</volume>
          <issue>2</issue>
          <fpage>239</fpage>
          <lpage>43</lpage>
          <pub-id pub-id-type="doi">10.1016/S0959-8049(96)00463-7</pub-id>
          <pub-id pub-id-type="pmid">9135495</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Coffin</surname>
              <given-names>CM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Pathologic features of rhabdomyosarcoma before and after treatment: a clinicopathologic and immunohistochemical analysis</article-title>
          <source>Mod Pathol</source>
          <year>1997</year>
          <volume>10</volume>
          <issue>12</issue>
          <fpage>1175</fpage>
          <lpage>87</lpage>
          <pub-id pub-id-type="pmid">9436961</pub-id>
        </element-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Smith</surname>
              <given-names>LM</given-names>
            </name>
            <name>
              <surname>Anderson</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Coffin</surname>
              <given-names>CM</given-names>
            </name>
          </person-group>
          <article-title>Cytodifferentiation and clinical outcome after chemotherapy and radiation therapy for rhabdomyosarcoma (RMS)</article-title>
          <source>Med Pediatr Oncol</source>
          <year>2002</year>
          <volume>38</volume>
          <issue>6</issue>
          <fpage>398</fpage>
          <lpage>404</lpage>
          <pub-id pub-id-type="doi">10.1002/mpo.10060</pub-id>
          <pub-id pub-id-type="pmid">11984800</pub-id>
        </element-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lowichik</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Therapy associated changes in childhood tumors</article-title>
          <source>Adv Anat Pathol</source>
          <year>2000</year>
          <volume>7</volume>
          <issue>6</issue>
          <fpage>341</fpage>
          <lpage>59</lpage>
          <pub-id pub-id-type="doi">10.1097/00125480-200007060-00002</pub-id>
          <pub-id pub-id-type="pmid">11078058</pub-id>
        </element-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Molenaar</surname>
              <given-names>WM</given-names>
            </name>
            <name>
              <surname>Oosterhuis</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Kamps</surname>
              <given-names>WA</given-names>
            </name>
          </person-group>
          <article-title>Cytologic &#x201C;differentiation&#x201D; in childhood rhabdomyosarcomas following polychemotherapy</article-title>
          <source>Hum Pathol</source>
          <year>1984</year>
          <volume>15</volume>
          <issue>10</issue>
          <fpage>973</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="doi">10.1016/S0046-8177(84)80127-6</pub-id>
          <pub-id pub-id-type="pmid">6479975</pub-id>
        </element-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Arndt</surname>
              <given-names>CA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Significance of persistent mature rhabdomyoblasts in bladder/prostate rhabdomyosarcoma: Results from IRS IV</article-title>
          <source>J Pediatr Hematol Oncol</source>
          <year>2006</year>
          <volume>28</volume>
          <issue>9</issue>
          <fpage>563</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="doi">10.1097/01.mph.0000212978.21372.97</pub-id>
          <pub-id pub-id-type="pmid">17006261</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
